| Literature DB >> 10688802 |
S A Priola1, A Raines, W S Caughey.
Abstract
The transmissible spongiform encephalopathies (TSEs) are fatal, neurodegenerative diseases for which no effective treatments are available. The likelihood that a bovine form of TSE has crossed species barriers and infected humans underscores the urgent need to identify anti-TSE drugs. Certain cyclic tetrapyrroles (porphyrins and phthalocyanines) have recently been shown to inhibit the in vitro formation of PrP-res, a protease-resistant protein critical for TSE pathogenesis. We now report that treatment of TSE-infected animals with three such compounds increased survival time from 50 to 300%. The significant inhibition of TSE disease by structurally dissimilar tetrapyrroles identifies these compounds as anti-TSE drugs.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10688802 DOI: 10.1126/science.287.5457.1503
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728